Stay updated on Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.

Latest updates to the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA newer revision entry (v3.6.6) was added to the study record history, while the earlier entry (v3.6.5) was removed, reflecting a small update to the page's revision metadata.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe study record history now includes a new revision entry labeled v3.6.5, replacing the previous v3.6.4. This update reflects the latest version metadata shown in the History tab.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry (v3.6.4) was added to the history, replacing the previous v3.6.3 entry to reflect a minor update to the page history. This appears to be metadata about page revisions rather than a modification to the study content or user-facing features.SummaryDifference0.1%

- Check70 days agoChange DetectedA new revision entry 'Revision: v3.6.3' was added to the Study Record History, replacing the previous 'Revision: v3.6.2'. This update reflects the latest version label in the history log without changing the study data or visible content.SummaryDifference0.1%

- Check77 days agoChange DetectedThe Study Record history now shows a newer revision (v3.6.2) replacing v3.6.0, indicating a minor behind-the-scenes update to the page.SummaryDifference0.1%

- Check92 days agoChange DetectedRecruitment status has changed to not recruiting participants, and the record history has been updated with a new v3.6.0 entry while removing the previous v3.5.5 entry.SummaryDifference0.3%

Stay in the know with updates to Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.